(Date:11/25/2009)..., disks placed under the skin kill tumor cells, st...Day News) -- A cancer vaccine delivered in a finge...ice, a new study reports. , The method uses pol...loaded with tumor-specific antigens and implanted ...ttack tumors. The Harvard University scientists wh...
(Date:11/25/2009)... BioSpace.com, the premier resou...iled the third edition of the BioForest™ Hot... Englewood, CO (Vocus) November 25, 2009 -- Bio...areers and information, unveiled the third edition...ing., , , , ,This regional campaign is a promotio...
(Date:11/25/2009)... SALTLAKECITY,Nov.25/PRNewswire/--dazzlesmile,llc ...w.optimalhealthscience.com havefileda67-pagefedera...gle.com,Inc.,JesseWillms,FarendServicesLimited,and...eUnitedStatesDistrictCourtfortheDistrictofUtah,all...azzlesmile(TM)brandedteethwhiteningproducts,violat...
(Date:11/25/2009)...STON - Two signaling pathways essential to normal ...dermal growth factor receptor (EGFR) pathways - in...n and metastasis, researchers from The University ...e Nov. 25 issue of Molecular Cell . , This newl...ng components known to correlate with invasive can...
(Date:11/25/2009)... press release is available in French . , , ...gies are about to enter the marketplace, thanks to...ed Partnership (Univalor) and Cognitive Sensing In...ed in Montreal. , Univalor, which commercializes... affiliated institutions, and CSI have announced t...
Breaking Medicine News(10 mins):Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries 2...TON, Aug. 15 The United States Agency,for Interna...nal $1 million,in assistance to the people of Geor...he total U.S. humanitarian assistance to $3.77 mil...d,canned foods as priority needs at this time. To ...
...LD, MA, Aug. 15 /PRNewswire-FirstCall/ - NUCRYST,P...dical products that,fight infection and inflammati...eived notice from The Nasdaq Stock Market stating ...S") of $5 million,required for continued listing o...
...ON, N.J., Aug. 15 Following is a,statement of Bet...sociation:, Horizon Blue Cross Blue Shield today ...rom a non-profit insurer to a publicly traded for-...e largest,provider of health benefits in the state...
...K, Aug. 15 The approval of Xenazine(R),(tetrabena... Huntington,s,Disease (HD), the first therapy to b...ificant milestone for all of our patients, familie... of,the symptoms of this devastating disease., "T...
...you,re over 55 and have spent more than a few slee... about half of all people over 55 -- but you may a...ilments. , Many older adults don,t get enough res...sion. Unfortunately, current sleeping pills are as...
... suggest why some people save while others spend ,...,t save money? Spending too much? Both? Don,t blam...and marketing experts have found that the time fra...eople think, ,We have no incentive, that,s why we ...
Other Medicine News:Health News:USAID Sends Humanitarian Assistance to the People of Georgia 2Health News:NUCRYST Receives Deficiency Notice from NASDAQ 2Health News:NUCRYST Receives Deficiency Notice from NASDAQ 3Health News:NJHA Raises Questions Regarding Horizon's Proposal to Convert to For-Profit Health Insurer 2Health News:HDSA Applauds Announcement of the First Therapy to be Approved for the Specific Treatment of a Symptom of Huntington's Disease 2Health News:A therapy for baby boomers to sleep on 2Health News:Money Matters 2Health News:Money Matters 3(Date:11/25/2009)..., BRIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgra...ne)tablets,anon-nucleosidereversetranscriptaseinhi...dicatedforuseintreatment-experiencedadultswhoareex...ttoanNNRTIandotherantiretroviral(ARV)agents.Thetra...tudiesknownasDUET-1andDUET-2.INTELENCEiscurrentlym...
(Date:11/25/2009)..., COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/-...ngcream-likefoamthatstopsseverebleeding,wonfirstpr...yoftheGlobalSecurityChallenge2009,companyofficials...sfromaroundtheworld,Remedium,steampitchedtheirinve...onSchoolofBusiness. ,, Remedium( www.remediumte...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBi...ntofantithromboticaptamerswithactivecontrolagents,...presentingatthePiperJaffray21stAnnualHealthCareCon...zo,spresentationwillbegivenat1:10pm(EST)onTuesday,...elinewithemphasisontheleaddevelopmentprogram,thean...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Obesity Contributes to Rapid Cartilage Loss 51575 1Obesity Contributes to Rapid Cartilage Loss 51575 2Obesity Contributes to Rapid Cartilage Loss 51575 3Obesity Contributes to Rapid Cartilage Loss 51575 4Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 1Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 2Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 3Elbit Imaging Ltd Announces Swiss Team Uses InSightecs ExAblate 28R 29 4000 Brain System to Treat Patients With Functional Brain Disorders 4721 4Simulating medical situations helps students learn retain basic science concepts 51568 1Simulating medical situations helps students learn retain basic science concepts 51568 2...ve Days of Continuous Control for Highly Feared Si... Expert Urges "Zero Tolerance" to Avoid Miss...akan Group,plc (LSE: PSK) today announced the U.S....SANCUSO(R) (Granisetron Transdermal System), the f...ive days of control of nausea,and vomiting for pat...
..., and BRUSSELS, Belgium, Sept. 15 ,Drais Pharmaceu... that they,have entered into a global agreement to...oscreen,s investigational drug and potential break...vered by Unibioscreen and is,currently in Phase I ...h,advanced solid tumors or lymphoma., "This is an...
Other Medicine Technology:F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy 2F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy 3F.D.A. Approves SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy 4Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer 2Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer 3Smart CompuBand
...The HALO Infant Protection System helps protect in...t to ensure the operating efficiencies, cost savin...ays busy and constrained healthcare facilities.,... reliable and versatile solution, but also unique-...
AgileTrac Infant Security
AeroScout Exciter: Choke-Point Location and Telemetry
Medicine Products: